Table 2.
Clinical recipients and post-operative outcome
| Age (y)a | 60 (55–68) |
| Sex | |
| Male (n) | 19 (79.2) |
| Female (n) | 5 (20.8) |
| BMI (kg/m2)a | 26 (22–28) |
| MELDa | 14 (11–18) |
| BAR scorea | 7 (7–10) |
| Total hospital stay (d)a | 21 (15–30) |
| ICU stay (d)a | 5 (3–9) |
| Early allograft dysfunction (n) | 9 (37) |
| Clavien Dindo > 3 | 11 (46) |
| Biliary complications (n) | 13 (54) |
| ≤Day 30 (n) | 9 (37) |
| >Day 30 (n) | 4 (17) |
| Biliary leakage (n) | 7 (29) |
| Anastomotic stricture (n) | 6 (25) |
| Arterial complication (n) | 5 (21) |
| Patient survival (d)a | 358 (83–591) |
| Graft survival (d)a | 358 (83–591) |
| 30 days patient survival (n) | 20 (83) |
| 30 days graft survival (n) | 20 (83) |
| Patient death (n) | 5 (21) |
| Follow-up (d)a | 143 (35–405) |
BMI body mass index; ICU intensive care unit; MELD model for end-stage liver disease; BAR balance of Risk; y years; d days; n number.
Values from n = 24 patients given in parentheses are percentages unless indicated otherwise.
aValues are median (IQR).